We are live on
!
Find out more
TERN
Terns Pharmaceuticals
TERN
TERN
Delisted
TERN was delisted on the 4th of May, 2026.
316 hedge funds and large institutions have $6.56B invested in Terns Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 130 funds opening new positions, 114 increasing their positions, 56 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
32% more funds holding in top 10
Funds holding in top 10: 19 → 25 (+6)
28% more funds holding
Funds holding: 247 → 316 (+69)
2.41% more ownership
Funds ownership: 136.09% → 138.51% (+2.4%)
Holders
316
Holding in Top 10
25
Calls
$440M
Puts
$257M
Top Buyers
| 1 | +$121M | |
| 2 | +$94.3M | |
| 3 | +$83.1M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$77.5M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$57.8M |
Top Sellers
| 1 | -$165M | |
| 2 | -$144M | |
| 3 | -$141M | |
| 4 |
O
OrbiMed
New York
|
-$87M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$78.4M |
